Immunotherapy for cancer: New method identifies target antigens by mass spectrometry

New cancer therapies harness the immune system to fight tumors. One of the main principles behind these therapies is to find out precisely which molecules on cancer cells trigger an immune response. A team of researchers has, for the first time, identified suitable protein structures directly from patients’ tumor cells. The procedure therefore opens up new possibilities for individualized targeted cancer treatments.

(via WSJ)